CHU Nice - Hôpital Pasteur

Nice 6001

0 studies enrolling now · 2 studies all time

What they study most

Idiopathic Pulmonary Fibrosis, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis — Stopped early
• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration — Completed